Paul MacLean
Concepts (667)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 59 | 2026 | 3131 | 5.070 |
Why?
| | Weight Gain | 26 | 2023 | 562 | 4.350 |
Why?
| | Energy Metabolism | 33 | 2025 | 930 | 4.250 |
Why?
| | Weight Loss | 28 | 2026 | 858 | 4.070 |
Why?
| | Physical Conditioning, Animal | 10 | 2025 | 243 | 2.320 |
Why?
| | Rats, Wistar | 19 | 2024 | 451 | 2.140 |
Why?
| | Energy Intake | 18 | 2025 | 507 | 2.070 |
Why?
| | Dietary Fats | 15 | 2026 | 307 | 1.950 |
Why?
| | Caloric Restriction | 9 | 2025 | 133 | 1.680 |
Why?
| | Ovariectomy | 11 | 2025 | 164 | 1.660 |
Why?
| | Body Weight | 16 | 2024 | 968 | 1.450 |
Why?
| | Lactation | 8 | 2020 | 193 | 1.400 |
Why?
| | Adipose Tissue | 15 | 2022 | 642 | 1.360 |
Why?
| | Appetite | 3 | 2025 | 80 | 1.280 |
Why?
| | Diet, High-Fat | 15 | 2023 | 267 | 1.280 |
Why?
| | Milk, Human | 6 | 2022 | 176 | 1.210 |
Why?
| | Body Composition | 12 | 2024 | 689 | 1.170 |
Why?
| | Ovary | 5 | 2024 | 236 | 1.120 |
Why?
| | Rats | 34 | 2024 | 5586 | 1.110 |
Why?
| | Adipocytes | 7 | 2025 | 223 | 1.080 |
Why?
| | Overweight | 7 | 2026 | 614 | 1.040 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1818 | 1.040 |
Why?
| | Animals | 87 | 2026 | 38107 | 1.020 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 47 | 1.000 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 79 | 0.990 |
Why?
| | Motor Activity | 3 | 2019 | 704 | 0.920 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 145 | 0.920 |
Why?
| | Lipid Metabolism | 9 | 2017 | 533 | 0.900 |
Why?
| | Appetite Regulation | 2 | 2017 | 31 | 0.840 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 568 | 0.790 |
Why?
| | Biomedical Research | 3 | 2023 | 729 | 0.760 |
Why?
| | Liver | 11 | 2024 | 1864 | 0.760 |
Why?
| | Cholesterol | 5 | 2019 | 411 | 0.750 |
Why?
| | Fasting | 7 | 2025 | 280 | 0.740 |
Why?
| | Milk | 6 | 2019 | 117 | 0.740 |
Why?
| | Leptin | 8 | 2025 | 248 | 0.730 |
Why?
| | Vasopressins | 3 | 2021 | 60 | 0.720 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 55 | 0.720 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 265 | 0.720 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 320 | 0.720 |
Why?
| | Awards and Prizes | 1 | 2023 | 72 | 0.720 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 18 | 0.720 |
Why?
| | Estrogens | 3 | 2018 | 364 | 0.720 |
Why?
| | Eating | 5 | 2022 | 386 | 0.720 |
Why?
| | Breast Feeding | 5 | 2022 | 447 | 0.710 |
Why?
| | Lipogenesis | 3 | 2019 | 62 | 0.700 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 124 | 0.690 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 61 | 0.690 |
Why?
| | Glycoproteins | 5 | 2005 | 356 | 0.660 |
Why?
| | Receptor, Insulin | 3 | 2015 | 92 | 0.660 |
Why?
| | Insulin | 19 | 2022 | 2525 | 0.640 |
Why?
| | Estradiol | 1 | 2024 | 517 | 0.630 |
Why?
| | Exercise | 11 | 2025 | 2213 | 0.610 |
Why?
| | Oxygen Consumption | 5 | 2019 | 721 | 0.610 |
Why?
| | Female | 69 | 2026 | 79499 | 0.600 |
Why?
| | Weight Reduction Programs | 4 | 2026 | 140 | 0.600 |
Why?
| | Thermogenesis | 2 | 2019 | 45 | 0.600 |
Why?
| | Physical Exertion | 3 | 2011 | 204 | 0.600 |
Why?
| | Breast Neoplasms | 7 | 2026 | 2418 | 0.600 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 216 | 0.600 |
Why?
| | Carrier Proteins | 6 | 2005 | 728 | 0.580 |
Why?
| | Cold Temperature | 2 | 2019 | 208 | 0.570 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 665 | 0.550 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 125 | 0.540 |
Why?
| | Menopause | 2 | 2019 | 328 | 0.540 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 59 | 0.530 |
Why?
| | Sex Characteristics | 3 | 2021 | 801 | 0.530 |
Why?
| | Calorimetry, Indirect | 6 | 2025 | 72 | 0.510 |
Why?
| | Diet | 10 | 2023 | 1273 | 0.510 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.510 |
Why?
| | Cortical Bone | 1 | 2017 | 18 | 0.510 |
Why?
| | Mice | 35 | 2026 | 18297 | 0.500 |
Why?
| | Insulin Resistance | 9 | 2025 | 1247 | 0.500 |
Why?
| | Adiposity | 5 | 2016 | 533 | 0.500 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.500 |
Why?
| | Diet, Reducing | 4 | 2021 | 90 | 0.490 |
Why?
| | Ibuprofen | 1 | 2017 | 87 | 0.490 |
Why?
| | Metformin | 2 | 2018 | 328 | 0.480 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.470 |
Why?
| | Placenta | 1 | 2023 | 794 | 0.470 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 5 | 0.470 |
Why?
| | Osteogenesis | 2 | 2017 | 205 | 0.460 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2599 | 0.460 |
Why?
| | Bone Density | 1 | 2019 | 494 | 0.460 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 406 | 0.450 |
Why?
| | Fructose | 5 | 2021 | 132 | 0.440 |
Why?
| | Oxytocin | 1 | 2015 | 51 | 0.440 |
Why?
| | Body Mass Index | 12 | 2026 | 2458 | 0.440 |
Why?
| | Therapies, Investigational | 1 | 2014 | 18 | 0.430 |
Why?
| | Male | 62 | 2026 | 73396 | 0.430 |
Why?
| | Mothers | 4 | 2018 | 772 | 0.420 |
Why?
| | Humans | 75 | 2026 | 146342 | 0.420 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 104 | 0.420 |
Why?
| | Feces | 7 | 2025 | 496 | 0.410 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 344 | 0.400 |
Why?
| | Transcription Factors | 13 | 2019 | 1730 | 0.400 |
Why?
| | Fatty Acids | 8 | 2022 | 460 | 0.390 |
Why?
| | Basal Metabolism | 3 | 2021 | 58 | 0.380 |
Why?
| | Fructokinases | 5 | 2021 | 42 | 0.380 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 55 | 0.380 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4580 | 0.370 |
Why?
| | Overnutrition | 1 | 2012 | 28 | 0.360 |
Why?
| | Fatty Liver | 5 | 2018 | 252 | 0.360 |
Why?
| | Pregnancy | 10 | 2023 | 7230 | 0.350 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 82 | 0.350 |
Why?
| | Blood Glucose | 10 | 2019 | 2360 | 0.350 |
Why?
| | Feeding Behavior | 5 | 2025 | 692 | 0.340 |
Why?
| | Recurrence | 4 | 2019 | 1133 | 0.340 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1101 | 0.340 |
Why?
| | Sheep | 4 | 2023 | 870 | 0.330 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 242 | 0.330 |
Why?
| | Estrous Cycle | 1 | 2010 | 21 | 0.320 |
Why?
| | Lipoproteins | 3 | 2000 | 165 | 0.310 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 32 | 0.310 |
Why?
| | Homeostasis | 7 | 2015 | 646 | 0.310 |
Why?
| | Gastrointestinal Microbiome | 4 | 2026 | 769 | 0.300 |
Why?
| | RNA, Messenger | 10 | 2019 | 2791 | 0.300 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 154 | 0.300 |
Why?
| | Vitamin D | 1 | 2013 | 402 | 0.300 |
Why?
| | Glucose | 10 | 2023 | 1053 | 0.300 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 24 | 0.290 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 147 | 0.280 |
Why?
| | Cattle | 6 | 2025 | 940 | 0.280 |
Why?
| | Huntington Disease | 2 | 2021 | 60 | 0.280 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 146 | 0.280 |
Why?
| | Mice, Inbred C57BL | 17 | 2026 | 6034 | 0.280 |
Why?
| | Time Factors | 11 | 2019 | 7109 | 0.280 |
Why?
| | Behavior Therapy | 2 | 2021 | 291 | 0.270 |
Why?
| | Adult | 34 | 2026 | 41087 | 0.270 |
Why?
| | Mice, Knockout | 13 | 2026 | 3125 | 0.270 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 35 | 0.260 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1242 | 0.260 |
Why?
| | Adiponectin | 5 | 2025 | 243 | 0.250 |
Why?
| | Triglycerides | 8 | 2019 | 527 | 0.240 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 71 | 0.240 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 585 | 0.240 |
Why?
| | Intestinal Absorption | 2 | 2026 | 103 | 0.240 |
Why?
| | Neurons | 1 | 2015 | 1668 | 0.240 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2219 | 0.240 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 306 | 0.230 |
Why?
| | Receptors, Lipoprotein | 1 | 2026 | 14 | 0.230 |
Why?
| | Birds | 2 | 2025 | 87 | 0.230 |
Why?
| | Dehydration | 2 | 2016 | 59 | 0.230 |
Why?
| | Campylobacter jejuni | 1 | 2025 | 16 | 0.230 |
Why?
| | Cattle Diseases | 1 | 2025 | 19 | 0.230 |
Why?
| | Campylobacter Infections | 1 | 2025 | 18 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 178 | 0.230 |
Why?
| | Epithelium | 2 | 2019 | 295 | 0.230 |
Why?
| | Lymphoma | 1 | 2007 | 251 | 0.220 |
Why?
| | Adenocarcinoma | 1 | 2012 | 927 | 0.220 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2623 | 0.220 |
Why?
| | Transcriptome | 4 | 2024 | 1068 | 0.220 |
Why?
| | Signal Transduction | 6 | 2022 | 5246 | 0.220 |
Why?
| | Fetal Development | 3 | 2023 | 297 | 0.220 |
Why?
| | Muscle Proteins | 4 | 2012 | 242 | 0.220 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 364 | 0.220 |
Why?
| | Leukemia | 1 | 2007 | 246 | 0.220 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.220 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 432 | 0.210 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1468 | 0.200 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.200 |
Why?
| | Escherichia coli O157 | 1 | 2023 | 14 | 0.200 |
Why?
| | Physical Fitness | 2 | 2016 | 209 | 0.200 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2026 | 233 | 0.200 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 266 | 0.200 |
Why?
| | Multiple Myeloma | 1 | 2007 | 310 | 0.200 |
Why?
| | Animals, Newborn | 3 | 2017 | 888 | 0.190 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 22 | 0.190 |
Why?
| | Middle Aged | 25 | 2026 | 36619 | 0.190 |
Why?
| | Resistance Training | 3 | 2017 | 186 | 0.190 |
Why?
| | Salmonella enterica | 1 | 2023 | 52 | 0.190 |
Why?
| | Arteriosclerosis | 1 | 2003 | 82 | 0.190 |
Why?
| | Financing, Organized | 1 | 2023 | 36 | 0.190 |
Why?
| | Animal Feed | 3 | 2019 | 50 | 0.190 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 441 | 0.190 |
Why?
| | Transcriptional Activation | 2 | 2002 | 369 | 0.190 |
Why?
| | Cell Proliferation | 3 | 2017 | 2502 | 0.190 |
Why?
| | Ghrelin | 3 | 2025 | 42 | 0.190 |
Why?
| | Hospitalization | 1 | 2013 | 2475 | 0.180 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1075 | 0.180 |
Why?
| | Parturition | 1 | 2023 | 72 | 0.180 |
Why?
| | Tamoxifen | 3 | 2021 | 193 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 152 | 0.180 |
Why?
| | Exercise Tolerance | 3 | 2016 | 289 | 0.170 |
Why?
| | Postmenopause | 4 | 2022 | 394 | 0.170 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1432 | 0.170 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 60 | 0.170 |
Why?
| | Mycoplasma ovipneumoniae | 1 | 2021 | 2 | 0.170 |
Why?
| | Malus | 1 | 2021 | 12 | 0.170 |
Why?
| | Lactoglobulins | 2 | 2018 | 6 | 0.170 |
Why?
| | Recombinases | 1 | 2021 | 10 | 0.170 |
Why?
| | Polyphenols | 1 | 2021 | 21 | 0.170 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 20 | 0.160 |
Why?
| | Mentors | 1 | 2023 | 217 | 0.160 |
Why?
| | Cancer Survivors | 1 | 2026 | 348 | 0.160 |
Why?
| | Thinness | 3 | 2021 | 100 | 0.160 |
Why?
| | Hygromycin B | 1 | 2000 | 3 | 0.160 |
Why?
| | Liver X Receptors | 2 | 2019 | 29 | 0.160 |
Why?
| | Child Development | 2 | 2018 | 481 | 0.160 |
Why?
| | Cinnamates | 1 | 2000 | 12 | 0.160 |
Why?
| | Disease Progression | 4 | 2018 | 2867 | 0.160 |
Why?
| | DNA Methylation | 2 | 2017 | 725 | 0.160 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2021 | 56 | 0.160 |
Why?
| | Shiga-Toxigenic Escherichia coli | 1 | 2020 | 10 | 0.160 |
Why?
| | Gene Expression Profiling | 3 | 2018 | 1792 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2001 | 115 | 0.160 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 144 | 0.160 |
Why?
| | Kynurenic Acid | 1 | 2020 | 18 | 0.160 |
Why?
| | Soil | 1 | 2021 | 147 | 0.150 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 196 | 0.150 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1432 | 0.150 |
Why?
| | Random Allocation | 2 | 2019 | 366 | 0.150 |
Why?
| | Starch | 1 | 2019 | 22 | 0.150 |
Why?
| | Nutritive Value | 1 | 2019 | 41 | 0.150 |
Why?
| | Escherichia coli Infections | 1 | 2020 | 125 | 0.150 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1130 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 455 | 0.150 |
Why?
| | Foodborne Diseases | 1 | 2020 | 60 | 0.140 |
Why?
| | Weaning | 1 | 2019 | 50 | 0.140 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.140 |
Why?
| | Analysis of Variance | 4 | 2016 | 1298 | 0.140 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2019 | 40 | 0.140 |
Why?
| | Metabolic Diseases | 2 | 2018 | 114 | 0.140 |
Why?
| | Ileitis | 1 | 2019 | 33 | 0.140 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 124 | 0.140 |
Why?
| | Anti-Infective Agents | 1 | 2021 | 234 | 0.140 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 55 | 0.140 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2134 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 198 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2537 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 47 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 48 | 0.140 |
Why?
| | Milk Hypersensitivity | 1 | 2018 | 18 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 163 | 0.140 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 35 | 0.140 |
Why?
| | Aromatase | 1 | 2018 | 37 | 0.140 |
Why?
| | Dairying | 3 | 2025 | 12 | 0.130 |
Why?
| | Glycogen | 6 | 2010 | 55 | 0.130 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.130 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.130 |
Why?
| | Rest | 1 | 2018 | 126 | 0.130 |
Why?
| | Models, Animal | 1 | 2019 | 387 | 0.130 |
Why?
| | Diglycerides | 1 | 2018 | 66 | 0.130 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 592 | 0.130 |
Why?
| | Postpartum Period | 2 | 2020 | 377 | 0.130 |
Why?
| | Malnutrition | 1 | 2019 | 87 | 0.130 |
Why?
| | Cell Size | 1 | 2017 | 95 | 0.130 |
Why?
| | Germ Layers | 1 | 2017 | 6 | 0.130 |
Why?
| | Gastrulation | 1 | 2017 | 9 | 0.130 |
Why?
| | Urea | 1 | 2017 | 84 | 0.130 |
Why?
| | Sucrose | 2 | 2018 | 113 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 83 | 0.130 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 80 | 0.130 |
Why?
| | Gene Editing | 1 | 2018 | 89 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2020 | 300 | 0.120 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 747 | 0.120 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 13 | 0.120 |
Why?
| | Chromatography, Gas | 1 | 2016 | 31 | 0.120 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 64 | 0.120 |
Why?
| | Running | 1 | 2019 | 235 | 0.120 |
Why?
| | Neural Pathways | 2 | 2011 | 319 | 0.120 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 200 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 307 | 0.120 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.120 |
Why?
| | Dyslipidemias | 1 | 2018 | 184 | 0.120 |
Why?
| | Glaucoma | 1 | 2020 | 267 | 0.120 |
Why?
| | Dogs | 1 | 2018 | 517 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2017 | 149 | 0.120 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 56 | 0.120 |
Why?
| | Paratuberculosis | 1 | 2015 | 2 | 0.120 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2015 | 3 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2017 | 181 | 0.120 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 725 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 17 | 0.110 |
Why?
| | Obesity, Morbid | 1 | 2000 | 287 | 0.110 |
Why?
| | Computational Biology | 1 | 2020 | 678 | 0.110 |
Why?
| | Hypothalamus | 1 | 2016 | 161 | 0.110 |
Why?
| | Jejunum | 1 | 2015 | 36 | 0.110 |
Why?
| | Down-Regulation | 3 | 2008 | 614 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 902 | 0.110 |
Why?
| | Up-Regulation | 3 | 2015 | 841 | 0.110 |
Why?
| | Fibroblasts | 2 | 2017 | 1034 | 0.110 |
Why?
| | Crohn Disease | 1 | 2019 | 250 | 0.110 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.110 |
Why?
| | Deer | 1 | 2015 | 52 | 0.110 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.110 |
Why?
| | Allergens | 1 | 2018 | 390 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2022 | 635 | 0.110 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 363 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Genetic Engineering | 1 | 2015 | 89 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1041 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 874 | 0.110 |
Why?
| | Trophoblasts | 1 | 2017 | 219 | 0.110 |
Why?
| | Caffeine | 1 | 1995 | 77 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 487 | 0.100 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 525 | 0.100 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 269 | 0.100 |
Why?
| | Arecaceae | 1 | 2014 | 2 | 0.100 |
Why?
| | Research Report | 1 | 2014 | 89 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 36 | 0.100 |
Why?
| | Fetus | 1 | 2019 | 800 | 0.100 |
Why?
| | Genes, Plant | 1 | 2014 | 46 | 0.100 |
Why?
| | Infant | 5 | 2023 | 10114 | 0.100 |
Why?
| | Acinar Cells | 1 | 2013 | 13 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 521 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1712 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 70 | 0.100 |
Why?
| | United States | 3 | 2023 | 16136 | 0.100 |
Why?
| | Animals, Wild | 2 | 2025 | 64 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 23 | 0.100 |
Why?
| | Mitochondria | 3 | 2022 | 997 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2017 | 250 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 118 | 0.090 |
Why?
| | Circadian Rhythm | 2 | 2009 | 515 | 0.090 |
Why?
| | Vitamin A | 1 | 2013 | 60 | 0.090 |
Why?
| | Genome | 1 | 2015 | 307 | 0.090 |
Why?
| | Lipoproteins, HDL | 2 | 2026 | 104 | 0.090 |
Why?
| | Integrases | 1 | 2013 | 117 | 0.090 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 8 | 0.090 |
Why?
| | Cell Separation | 1 | 2013 | 300 | 0.090 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 212 | 0.090 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 666 | 0.090 |
Why?
| | Cytoskeleton | 1 | 2013 | 180 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 823 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 134 | 0.090 |
Why?
| | Alleles | 1 | 2015 | 907 | 0.090 |
Why?
| | Histones | 1 | 2017 | 670 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2020 | 1119 | 0.090 |
Why?
| | Research Design | 1 | 2018 | 1143 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 33 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 163 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2013 | 310 | 0.080 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 65 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 189 | 0.080 |
Why?
| | Biomarkers | 6 | 2019 | 4340 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2488 | 0.080 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2219 | 0.080 |
Why?
| | Glycolysis | 1 | 2012 | 342 | 0.080 |
Why?
| | Phylogeny | 3 | 2021 | 924 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 385 | 0.080 |
Why?
| | Colon | 1 | 2013 | 304 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 589 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2018 | 6460 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4595 | 0.080 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 21 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 42 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 384 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 996 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 41 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 263 | 0.080 |
Why?
| | Intestine, Small | 2 | 2026 | 160 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 268 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 23 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 319 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 543 | 0.070 |
Why?
| | Hypertension | 1 | 2018 | 1272 | 0.070 |
Why?
| | Fats | 1 | 2009 | 13 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 199 | 0.070 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 201 | 0.070 |
Why?
| | Adolescent | 6 | 2025 | 22557 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2009 | 207 | 0.070 |
Why?
| | Health Behavior | 1 | 2014 | 802 | 0.070 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 168 | 0.070 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 352 | 0.070 |
Why?
| | Young Adult | 6 | 2025 | 14330 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 870 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 339 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 193 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 434 | 0.070 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1412 | 0.070 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2023 | 507 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 615 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1724 | 0.060 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 28 | 0.060 |
Why?
| | Hyperplasia | 1 | 2008 | 164 | 0.060 |
Why?
| | Antigens, CD34 | 1 | 2007 | 89 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 175 | 0.060 |
Why?
| | Risk Factors | 3 | 2018 | 10921 | 0.060 |
Why?
| | Animals, Genetically Modified | 2 | 2018 | 248 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2016 | 11821 | 0.060 |
Why?
| | Nuclear Transfer Techniques | 2 | 2017 | 5 | 0.060 |
Why?
| | Patient Selection | 2 | 2009 | 728 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 106 | 0.060 |
Why?
| | Leukocyte Count | 1 | 2007 | 321 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2814 | 0.060 |
Why?
| | Chylomicrons | 1 | 2026 | 18 | 0.060 |
Why?
| | Lactates | 3 | 1995 | 82 | 0.060 |
Why?
| | Proof of Concept Study | 1 | 2026 | 90 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 637 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 69 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 193 | 0.060 |
Why?
| | Multilocus Sequence Typing | 1 | 2025 | 16 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 784 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 59 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 796 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 81 | 0.060 |
Why?
| | Peptide YY | 1 | 2025 | 28 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1982 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1761 | 0.050 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 39 | 0.050 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 6 | 0.050 |
Why?
| | Lipolysis | 1 | 2005 | 44 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2019 | 3647 | 0.050 |
Why?
| | Population Dynamics | 1 | 2025 | 142 | 0.050 |
Why?
| | Disease Resistance | 2 | 2015 | 30 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1763 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2018 | 17438 | 0.050 |
Why?
| | Proteins | 2 | 2013 | 1022 | 0.050 |
Why?
| | Proteomics | 2 | 2022 | 1203 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2025 | 3017 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 213 | 0.050 |
Why?
| | Kinetics | 2 | 2012 | 1553 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 155 | 0.050 |
Why?
| | Organ Specificity | 1 | 2005 | 307 | 0.050 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 45 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1532 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 51 | 0.050 |
Why?
| | Manure | 1 | 2023 | 7 | 0.050 |
Why?
| | Antigens, CD | 1 | 2007 | 560 | 0.050 |
Why?
| | Pilot Projects | 2 | 2022 | 1888 | 0.050 |
Why?
| | Colony Count, Microbial | 1 | 2023 | 90 | 0.050 |
Why?
| | Food Microbiology | 1 | 2023 | 39 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 5 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 372 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 633 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 268 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 311 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 28 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 41 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 18 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 278 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 295 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 112 | 0.050 |
Why?
| | Sex Factors | 2 | 2019 | 2107 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 56 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 78 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2113 | 0.040 |
Why?
| | Aged | 5 | 2018 | 26432 | 0.040 |
Why?
| | Leucine | 1 | 2022 | 116 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2026 | 1488 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 61 | 0.040 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 80 | 0.040 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 39 | 0.040 |
Why?
| | Rodentia | 1 | 2022 | 63 | 0.040 |
Why?
| | Dinoprostone | 1 | 2022 | 179 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 141 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 91 | 0.040 |
Why?
| | Clostridium | 1 | 2021 | 19 | 0.040 |
Why?
| | Bacillus | 1 | 2021 | 18 | 0.040 |
Why?
| | Mice, Obese | 1 | 2021 | 68 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 13 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2026 | 1135 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2003 | 219 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.040 |
Why?
| | Neutrophils | 1 | 2007 | 1133 | 0.040 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 81 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 142 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 215 | 0.040 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 39 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 326 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 74 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 44 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 351 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 82 | 0.040 |
Why?
| | Farms | 1 | 2020 | 8 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1879 | 0.040 |
Why?
| | Molecular Typing | 1 | 2020 | 21 | 0.040 |
Why?
| | Hemoglobins | 1 | 2023 | 384 | 0.040 |
Why?
| | Metabolomics | 1 | 2026 | 738 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 257 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 70 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 128 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 750 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2021 | 334 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 105 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 108 | 0.040 |
Why?
| | Plasmids | 1 | 2021 | 373 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 275 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 2240 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 3 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 119 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 9 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 17 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 44 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2026 | 881 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 250 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 56 | 0.040 |
Why?
| | Ileostomy | 1 | 2019 | 25 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 48 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 8391 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 114 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 218 | 0.040 |
Why?
| | Child | 2 | 2022 | 22693 | 0.030 |
Why?
| | Mathematical Concepts | 1 | 2018 | 35 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.030 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 117 | 0.030 |
Why?
| | Prospective Studies | 2 | 2023 | 8123 | 0.030 |
Why?
| | Area Under Curve | 1 | 2019 | 335 | 0.030 |
Why?
| | Colectomy | 1 | 2019 | 119 | 0.030 |
Why?
| | Japan | 1 | 2018 | 149 | 0.030 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5899 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1998 | 0.030 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.030 |
Why?
| | Transfection | 1 | 2000 | 916 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 33 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 123 | 0.030 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2017 | 45 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2018 | 190 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 28 | 0.030 |
Why?
| | Cytokines | 2 | 2018 | 2081 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1224 | 0.030 |
Why?
| | Muscle Contraction | 1 | 2000 | 438 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 506 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 663 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 144 | 0.030 |
Why?
| | Blastocyst | 1 | 2017 | 50 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 28 | 0.030 |
Why?
| | Breast | 1 | 2018 | 155 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 208 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 44 | 0.030 |
Why?
| | Meat | 1 | 2018 | 62 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 627 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 215 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 167 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 370 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 294 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 214 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 617 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2954 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.030 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 137 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2991 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 270 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 241 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 160 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1163 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 192 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 360 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 750 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 160 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 150 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 109 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 226 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 121 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 613 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 857 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 212 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 187 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2015 | 21 | 0.030 |
Why?
| | Biological Products | 1 | 2019 | 258 | 0.030 |
Why?
| | Endonucleases | 1 | 2015 | 35 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2015 | 50 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 453 | 0.030 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 36 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 44 | 0.030 |
Why?
| | Gestational Age | 1 | 2019 | 990 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1369 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4118 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 360 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 2070 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 846 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1181 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1075 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 87 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 316 | 0.030 |
Why?
| | RNA, Plant | 1 | 2014 | 10 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2014 | 43 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 729 | 0.030 |
Why?
| | Gene Ontology | 1 | 2014 | 55 | 0.030 |
Why?
| | Genetic Loci | 1 | 2015 | 273 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 396 | 0.020 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2014 | 110 | 0.020 |
Why?
| | Perfusion | 1 | 1995 | 255 | 0.020 |
Why?
| | Cell Respiration | 1 | 2013 | 104 | 0.020 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 27 | 0.020 |
Why?
| | Testosterone | 1 | 2017 | 419 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3416 | 0.020 |
Why?
| | Plant Proteins | 1 | 2014 | 110 | 0.020 |
Why?
| | Betaine | 1 | 2013 | 66 | 0.020 |
Why?
| | Lipids | 1 | 1998 | 714 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 83 | 0.020 |
Why?
| | Muscles | 1 | 1994 | 330 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 159 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 2019 | 609 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 511 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 154 | 0.020 |
Why?
| | Plant Leaves | 1 | 2014 | 134 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 712 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 144 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 144 | 0.020 |
Why?
| | Base Sequence | 1 | 2015 | 2123 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1765 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2861 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 752 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 771 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2838 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2921 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1463 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 319 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 44 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 508 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1942 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 90 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5439 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 16 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3545 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 490 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3712 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3206 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 520 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 372 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 699 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 610 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 228 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 992 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 28 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 21 | 0.010 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 14 | 0.010 |
Why?
| | Breeding | 1 | 2006 | 64 | 0.010 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 32 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3926 | 0.010 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 29 | 0.010 |
Why?
| | PPAR alpha | 1 | 2006 | 56 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 33 | 0.010 |
Why?
| | Adenoviridae | 1 | 2006 | 197 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 228 | 0.010 |
Why?
| | Introns | 1 | 2005 | 257 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2006 | 212 | 0.010 |
Why?
| | Mutation | 1 | 2015 | 4093 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 60 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 9 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 48 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 51 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 128 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 27 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 139 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 217 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2919 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 759 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1996 | 0.010 |
Why?
| | RNA | 1 | 2003 | 926 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 872 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 10 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 295 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 6 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 326 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 88 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3347 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1177 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 507 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|